Dataset from A Phase 3, Randomized, Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine Manufactured With and Without Polysorbate 80 in Healthy Infants Given in a 2-, 3-, 4-, and 12-Month Schedule With Routine Pediatric Vaccinations
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006792
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the safety, tolerability and immunogenicity of a
13-valent pneumococcal conjugate (13vPnC) vaccine manufactured with Polysorbate 80 compared
to a 13-valent pneumococcal conjugate (13vPnC) manufactured without Polysorbate 80 when given
concomitantly with routine paediatric vaccinations.
创建时间：
2024-11-27
